NATIXIS ADVISORS, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1018331 Boston, MA

Position in UTHR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$9,042,352

+$3,308,394 QoQ

Shares Held

15,249

+29.6% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $166,492,947 across 17 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	9,198,299	$92,074,972
2	TEVA	Teva Pharmaceutical Industries Ltd	565,862	$17,043,763
3	PBH	Prestige Consumer Healthcare Inc.	253,753	$15,039,940
4	UTHR	UNITED THERAPEUTICS Corp This page	15,249	$9,042,352
5	ZTS	Zoetis Inc.	65,865	$7,785,901
6	TAK	Takeda Pharmaceutical Co Ltd	324,034	$6,001,109
7	NBIX	Neurocrine Biosciences Inc	43,597	$5,743,468
8	VTRS	Viatris Inc	234,320	$3,165,663

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,042,352	15,249	+29.6%	Shares	Defined	2026-05-13
2025-12-31	$5,733,958	11,768	+0.5%	Shares	Defined	2026-02-10
2025-09-30	$4,911,045	11,715	-4.4%	Shares	Other	2025-11-13
2025-06-30	$3,519,462	12,248	-89.7%	Shares	Other	2025-08-13
2025-03-31	$36,555,271	118,582	+763.4%	Shares	Other	2025-05-08
2024-12-31	$4,846,257	13,735	-19.3%	Shares	Other	2025-02-10
2024-09-30	$6,095,891	17,011	-4.2%	Shares	Other	2024-11-06
2024-06-30	$5,654,262	17,750	+7.1%	Shares	Other	2024-08-01
2024-03-31	$3,808,986	16,581	+3.3%	Shares	Other	2024-04-25
2023-12-31	$3,529,233	16,050	-24.7%	Shares	Other	2024-02-06
2023-09-30	$4,815,322	21,319	+56.6%	Shares	Other	2023-11-13
2023-06-30	$3,005,952	13,617	+13.4%	Shares	Other	2023-08-15
2023-03-31	$2,688,639	12,005	—	Shares	Other	2023-05-11
No filing history on record for this holder in this stock.